StaBLE: Stability and Balance in Locomotion Through Exercise

Sponsor
University of Erlangen-Nürnberg (Other)
Overall Status
Completed
CT.gov ID
NCT01856244
Collaborator
German Foundation for Neurology (Other), Department of Molecular Neurology, Faculty of Medicine, University Erlangen-Nürnberg (Other)
48
1
2
36
1.3

Study Details

Study Description

Brief Summary

Persons with Morbus Parkinson commonly develop gait and balance disorders leading to dependence, loss of mobility and a high risk of falling.

This study investigates the effectiveness of a sensorimotor treadmill intervention to improve walking and balance abilities in persons with early stages of Parkinson's disease. The sensorimotor treadmill training is conducted on a special treadmill device which is challenging the participants by small oscillations. This intervention, which is supposed to simulate walking on natural, uneven surfaces, is compared to a conventional treadmill training.

Hypothesis: Sensorimotor treadmill training leads to larger improvements in walking and balance abilities as compared to conventional treadmill exercise.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: treadmill walking
  • Device: Treadmill
Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Sensorimotor Treadmill Training to Improve Gait and Balance in Parkinson's Disease
Study Start Date :
Jun 1, 2013
Actual Primary Completion Date :
Jun 1, 2016
Actual Study Completion Date :
Jun 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: sensorimotor treadmill training

specific treadmill control using oscillating platform

Behavioral: treadmill walking

Device: Treadmill

Active Comparator: conventional treadmill training

conventional treadmill control

Behavioral: treadmill walking

Device: Treadmill

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline Gait Speed [8 weeks and 20 weeks]

    Self selected walking speed is assessed on a 10 meter walk distance

  2. Change from Baseline Balance [8 weeks and 20 weeks]

    Mini - Balance Evaluation Systems Test (Mini - BESTest), Postural Sway in the Romberg Test with eyes open and eyes closed for 30 seconds

Secondary Outcome Measures

  1. Change from Baseline Gait Performance [8 weeks and 20 weeks]

    Two Minute Walk Test (2MWT), Timed "up-and-go" Test, Assessment of tempo-spatial gait parameters

  2. Change from Baseline Mobility [8 weeks and 20 weeks]

    Rivermead Mobility Index

  3. Change from Baseline Unified Parkinson's Disease Rating Scale (UPDRS) [8 weeks and 20 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Parkinson's disease stage 1-3 Hoehn and Yahr

  • United Parkinson Disease Rating Scale (UPDRS) 'gait' or 'postural stability' subscore of 1 or more

  • Ability to stand unaided and walk without an assistive device

  • Stable medication during the study period

Exclusion Criteria:
  • On-off and wearing-off phenomena

  • Unstable medical or psychiatric illness

  • Clinically relevant cardiovascular or orthopaedic disease

  • Severe polyneuropathy

  • Cognitive impairment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Institute of Sport Science and Sport, Gebbertstr. 123b Erlangen Germany 91058

Sponsors and Collaborators

  • University of Erlangen-Nürnberg
  • German Foundation for Neurology
  • Department of Molecular Neurology, Faculty of Medicine, University Erlangen-Nürnberg

Investigators

  • Principal Investigator: Klaus Pfeifer, Prof. Dr., Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Institute of Sport Science and Sport

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Prof. Dr. Klaus Pfeifer, Prof. Dr., University of Erlangen-Nürnberg
ClinicalTrials.gov Identifier:
NCT01856244
Other Study ID Numbers:
  • DSN-0613
First Posted:
May 17, 2013
Last Update Posted:
Oct 5, 2016
Last Verified:
Oct 1, 2016
Keywords provided by Prof. Dr. Klaus Pfeifer, Prof. Dr., University of Erlangen-Nürnberg
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2016